RxSight Inc (RXST)
44.83
-0.22
(-0.49%)
USD |
NASDAQ |
Nov 22, 16:00
44.85
+0.02
(+0.04%)
After-Hours: 20:00
RxSight Free Cash Flow: -27.17M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -27.17M |
| June 30, 2024 | -35.35M |
| March 31, 2024 | -39.17M |
| December 31, 2023 | -46.41M |
| September 30, 2023 | -50.73M |
| June 30, 2023 | -57.86M |
| March 31, 2023 | -64.40M |
| December 31, 2022 | -61.24M |
| Date | Value |
|---|---|
| September 30, 2022 | -56.11M |
| June 30, 2022 | -54.36M |
| March 31, 2022 | -51.25M |
| December 31, 2021 | -46.65M |
| September 30, 2021 | -46.33M |
| June 30, 2021 | -39.87M |
| March 31, 2021 | -35.43M |
| December 31, 2020 | -37.74M |
Free Cash Flow Range, Past 5 Years
-64.40M
Minimum
Mar 2023
-27.17M
Maximum
Sep 2024
-46.88M
Average
-46.53M
Median
Free Cash Flow Benchmarks
| Tandem Diabetes Care Inc | -37.35M |
| PROCEPT BioRobotics Corp | -103.56M |
| Perspective Therapeutics Inc | -40.58M |
| Xtant Medical Holdings Inc | -17.28M |
| Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.65M |
| Cash from Investing (Quarterly) | -9.26M |
| Cash from Financing (Quarterly) | 0.878M |
| Free Cash Flow Per Share (Quarterly) | -0.0114 |
| Free Cash Flow to Equity (Quarterly) | -0.453M |
| Free Cash Flow to Firm (Quarterly) | -0.453M |
| Free Cash Flow Yield | -1.60% |